DNTH vs L · rev $6.2M vs P/E 14, rev $18.45B
Dianthus Therapeutics Inc. (DNTH) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
DNTH currently screens at market cap $4.40B. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the DNTH and L stock pages for the full models.
Not investment advice.